MK-677 vs GHRP-2
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Ibutamoren, Nutrobal
An orally active growth hormone secretagogue that mimics ghrelin. Although technically not a peptide, it is frequently discussed alongside GH peptides due to similar effects.
Also: Growth Hormone Releasing Peptide 2, Pralmorelin
A synthetic hexapeptide that potently stimulates GH release. More potent than GHRP-6 with less appetite stimulation, but still elevates cortisol and prolactin.
Key Comparison Insights
- Both peptides belong to the Growth Hormone category, suggesting similar primary applications.
Detailed Comparison
| Attribute | MK-677 | GHRP-2 |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | MK-677 binds to ghrelin receptors (GHSR) in the brain, stimulating sustained GH release and increasing IGF-1 levels. Unlike injectable GHRPs, it is orally bioavailable and has a long half-life providing 24-hour GH elevation. | GHRP-2 acts on ghrelin receptors to stimulate GH release from the pituitary. It has the strongest GH-releasing effect among GHRPs but also causes more cortisol and prolactin release than ipamorelin. Less appetite stimulation than GHRP-6. |
| Common Dosing | 10-25 mg daily Once daily, often before bed | 100-300 mcg 2-3x daily 2-3x daily |
| Administration | Oral | Subcutaneous injection |
| Typical Duration | 8-12 weeks or longer | 8-12 weeks |
| Best Time to Take | Before bed | Before bed or morning (fasted) |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Studies show increases in GH and IGF-1 levels, improved sleep quality, and increased lean body mass. However, a clinical trial was stopped early due to heart failure concerns in elderly patients. FDA lists MK-677 as having 'significant safety risks due to potential for congestive heart failure.' December 2025: FDA issued warning letters to companies selling MK-677. Never received FDA approval and remains an unapproved drug. | Studies show it produces the highest GH release among common GHRPs. Research demonstrates reliable diagnostic use for GH deficiency testing. Animal studies show improved muscle mass and recovery. |
Frequently Asked Questions: MK-677 vs GHRP-2
What is the difference between MK-677 and GHRP-2?
MK-677 is a growth hormone peptide that an orally active growth hormone secretagogue that mimics ghrelin. although technically not a peptide, it is frequently discussed alongside gh peptides due to similar effects. GHRP-2 is a growth hormone peptide that a synthetic hexapeptide that potently stimulates gh release. more potent than ghrp-6 with less appetite stimulation, but still elevates cortisol and prolactin. The main differences lie in their mechanisms of action and clinical applications.
Which is better, MK-677 or GHRP-2?
Neither is universally "better" - the choice depends on your specific goals. MK-677 is typically used for growth hormone purposes, while GHRP-2 is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can MK-677 and GHRP-2 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using MK-677 and GHRP-2 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.